Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

Symptoms associated with gastroesophageal reflux disease are frequently overtreated in infants, according to a new study by researchers in Michigan and Missouri.

Three high school seniors from Topeka, Kan., won a contest that sponsors hope will lead to better health outcomes while also getting young people interested in pharmacy careers.

The Food and Drug Administration has approved a new drug made by Johnson & Johnson for treating Type 2 diabetes, the agency said.

An executive from Diplomat Specialty Pharmacy recently participated in a program on hepatitis C therapy, the company said.

Hamacher Resource Group has been invited to present a continuing education session, “Bottom Line Performance: Opportunities and Actions,” at the Mutual Drug Spring CE Forum on April 7 in Raleigh, N. C., the company announced.

The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

Pharmacies using McKesson EnterpriseRx pharmacy-management system can send patients information about health clinics, drug recalls, coupons and real-time surveys through their mobile phones using an integrated mobile communication system.

The Food and Drug Administration has approved a drug for opioid dependence made by Actavis, the company said.

It’s often the case that those in the midst of revolutionary times don’t really see how fundamentally the world around them is changing until long after the changes have occurred. So let’s start by declaring that the revolution has begun: Genomic research will dramatically transform both the practice of pharmacy and the way patients are treated with medications for many diseases.

The sequencing of the human genome was a huge scientific breakthrough, and it’s spawning additional breakthroughs as genetic testing labs spring up and the cost of testing individual patients for their ability to metabolize a particular drug drops to affordable levels for health plan payers.

The percentage of people who are at risk of developing Type 2 diabetes and aware of it has risen slightly over the past few years, but remains low, according to a report by the Centers for Disease Control and Prevention.

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.